- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
课件:最新重症哮喘最新治疗进展.ppt
* 13-14岁人群中重症哮喘高发区域 图中圆形标记的是拉丁美洲,原文的出处是第3页,“centres with the highest prevalence of severe asthma symptoms (7.5%) were mostly found in the English language countries and Latin America”,图中红色聚集的位置正是下页幻灯所提到的巴西 原文的注释是:Figure 2 Prevalence of symptoms of severe asthma according to the written questionnaire in the 13–14 year age group. See text for definition of symptoms of severe asthma. The symbols indicate prevalence values of ,2.5% (blue square), 2.5 to ,5% (green circle), 5 to ,7.5% (yellow diamond) and .7.5% (red star). * 免费向巴西重症哮喘患者提供吸入性糖皮质激素(ICS)后,住院率显著下降,政府及家庭的医疗费用均下降,医疗负担减轻。 原文的注释是:FIGURE 2. Asthma hospitalisation rates ($), the number of patients enrolled in the Programme for Control of Asthma in Bahia (h) and the number of dispensed units of medication containing inhaled corticosteroids () as a single medicine or in combination in Salvador, Brazil from 2002 to 2006. ICS: inhaled corticosteroids. * GINA2014指南第36页最上方 * * * 过敏性支气管肺真菌病 allergic bronchopulmonary mycoses (ABPM) 阿司匹林加重呼吸系统疾病 aspirin-exacerbated respiratory disease (AERD) 过敏性支气管肺曲霉菌病 Allergic Bronchopulmonary Aspergillosis(ABPA) 有关哮喘表型和内型的原文摘要解释如下: A phenotype is defined as the integration of different characteristics that are the product of the interaction of the patient’s genes with the environment. Both clinical and statistical approaches have identified at least 3–5 phenotypes of severe asthma. However, these phenotypes, in isolation, do not identify the immunopathology that makes these clinical phenotypes distinct or identifies a target population for a specific approach to therapy. As biological characteristics are identified, phenotypes should continue to evolve towards asthma endotypes. The identification of these endotypes, either by matching biology, genetics and therapeutic responses to therapy with clinically or statistically defined phenotypes or through unbiased genetic and genomic approaches, remains limited. * exercise-induced asthma (EIA) 运动诱发型哮喘 aspirin-exacerbated respiratory di
您可能关注的文档
最近下载
- (正式版)DB2306∕T 192-2024 《大庆市海绵城市规划设计导则》.pdf VIP
- 信用卡培训课件.ppt VIP
- 2022年石家庄市深泽县医院医护人员招聘考试试题及答案解析.docx VIP
- 建筑施工企业资金风险因素分析与对策探讨.pdf VIP
- 《机械设计基础》第五版10章连接.ppt VIP
- 整体式履带行走机构驱动轮设计及CAE分析.doc VIP
- 2025年广东省华南师范大学附属中学 初三物理自主招生试题 .pdf VIP
- 全国失信被执行人名单查询网查询【官网入口】.doc VIP
- 2021年石家庄市深泽县人民医院医护人员招聘试题及答案解析.docx VIP
- 松下NPM贴片机高级培训教材.pdf VIP
原创力文档


文档评论(0)